APR Medicube Cream Cleared of Banned Dye After Singapore HSA Recall
South Korean beauty firm APR found no Sudan Red dye in Medicube skin cream batches. This follows a Singapore Health Sciences Authority (HSA) recall. APR disputes the origin of HSA's initial samples.
APR Disputes Sample Authenticity
South Korean beauty company APR reported laboratory tests found no Sudan Red dye in two batches of its Medicube skin cream. Singapore's Health Sciences Authority (HSA) had previously flagged these batches in a recall. Certified institutions, including one in Korea, conducted the testing.
APR sent samples of Medicube's PDRN Pink Collagen Capsule Cream corresponding to the specific batch numbers cited by HSA. Sudan Red is a synthetic azo dye, banned in foods and cosmetics due to suspected genotoxic (damaging to genetic material) and carcinogenic (cancer-causing) properties. APR stated these results confirm no Sudan Red was detected in products with the cited batch numbers.
HSA Findings and Company Response
APR's tests align with HSA's own findings of no Sudan Red detection in products officially supplied by APR's Singapore entity. The company also conducted testing at an HSA-certified institution at the regulator's request. HSA's initial discovery of trace Sudan IV amounts occurred in two batches sold by Venus Beauty Pte. Ltd. This distributor was one of three under HSA scrutiny.
The regulator ordered these specific batches recalled on Aug. 26. HSA cleared other distributors' batches, including APR's official Singapore distributor, for resale after finding no contamination.
Supply Chain Integrity Questions
APR disputes the authenticity of the samples HSA initially tested. The company stated it has no record of exporting those specific batch numbers to Singapore. APR noted HSA identified Venus Beauty as the seller of the tested samples. APR asserts it has never supplied or exported products to Venus Beauty.
An APR official stated the company is reviewing how these products were distributed. Questions remain regarding the genuineness of HSA's samples and their path to that particular seller. This incident highlights the importance of robust supply chain verification for consumer goods in Asia.
This article is journalism, not investment advice; consult a licensed professional before making financial decisions. Market data is indicative, may be delayed, and should be verified with your broker or exchange before use.
Comments.
Comments are moderated. We remove what is unlawful, abusive or off-topic, and and you remain responsible for what you post.
Reader comments open soon. Until then, corrections and responses go to our newsroom, and we publish what we get wrong on Corrections.